Oncolytics Biotech names chief medical officer

Wednesday, July 6, 2011 10:46 AM

Oncolytics Biotech has named George M. Gill, M.D., chief medical officer.

He had been senior vice president of clinical safety and regulatory affairs and an officer of Oncolytics since 2002.

"Dr. Gill has an outstanding track record, having supported the advancement of more than 20 products—including 11 anti-cancer agents—through the clinical research and regulatory approval process in the United States, Canada and Europe," said Dr. Brad Thompson, president  and CEO of Oncolytics.

Previously he was vice president of clinical research and medical affairs at Ligand Pharmaceuticals; senior director and head of U.S. clinical and medical affairs for ICI Pharmaceuticals and vice president and head of worldwide regulatory affairs for Bristol-Myers.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs